Last reviewed · How we verify

NCT03924141

Evaluation of Training in De-escalation

Completed NA Last updated 5 August 2020
What this trial tests

NA trial testing Training in de-escalation in De-escalation Skills in 45 participants. Completed in 30 June 2020.

Timeline
18 February 2019
Primary endpoint
26 November 2019
30 June 2020

Quick facts

Lead sponsorBergen University College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment45
Start date18 February 2019
Primary completion26 November 2019
Estimated completion30 June 2020
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Bergen University College

Who can join

Adults 18 to 60, any sex, with De-escalation Skills. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate one of the chapters in the new national Norwegian training manual (MAP). The chapter that is selected to be evaluated is the chapter on de-escalation. Effective training in this topic should not only lead to changes in the level of knowledge and attitudes, but also changes in behavior and skills. Experiencing better preparedness does not necessarily entail a change in behavior. This study wants to test whether training in de-escalation changes the participants' skills and experience of self-confidence, security and coping in threatening situations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Bergen University College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03924141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing